Why the study?
Does fixed combination amlodipine/atorvastatin improve treatment adherence in hypertensive patients with dyslipidemia?
Does fixed combination amlodipine/atorvastatin improve treatment adherence in hypertensive patients with dyslipidemia?
Answers are grounded in this paper and cite their sources.
This review discusses strategies to improve treatment adherence in patients with hypertension and dyslipidemia, focusing on the fixed-dose combination of amlodipine and atorvastatin.
The article addresses the problem of treatment hypertensive patients with dyslipidemia. Questions of adherence to antihypertensive and lipid-lowering therapy are discussed. Effects of first fixed combination CADUET (amlodopine/atorvastatin) dealing with more than one risk factor are analyzed.
No takes yet. Share an insight, caveat, or question.
Yu. M. Lopatin (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: